colorectal cancer

Low-Dose Aspirin May Cut Risk Of Developing And Dying From Colon Cancer

A pooled analysis of five trials with 20 years of follow up suggests that taking a low dose of aspirin may cut the risk of developing and dying from colon cancer, the second most common cancer in developed countries after lung cancer.

,

A New Indicator Of Poor Prognosis In Node-Negative Colorectal Cancer Patients

Tumor budding at the invasive tumor front of colorectal cancer is recognized as an independent prognostic factor significantly related to both lymph node and distant metastasis.

, ,